Cardinal Health (NYSE:CAH) Releases FY 2025 Earnings Guidance

Cardinal Health (NYSE:CAH - Get Free Report) issued an update on its FY 2025 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of 7.500- for the period, compared to the consensus estimate of 7.870. The company issued revenue guidance of -.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on CAH shares. UBS Group lifted their price target on shares of Cardinal Health from $122.00 to $125.00 and gave the company a buy rating in a report on Monday, February 5th. Robert W. Baird lowered their price target on Cardinal Health from $134.00 to $128.00 and set an outperform rating for the company in a research report on Friday. Argus upgraded Cardinal Health from a hold rating to a buy rating in a report on Friday, February 9th. Wells Fargo & Company reduced their price objective on Cardinal Health from $96.00 to $94.00 and set an underweight rating on the stock in a research note on Monday. Finally, Evercore ISI increased their target price on shares of Cardinal Health from $110.00 to $115.00 and gave the stock an in-line rating in a research report on Friday. One analyst has rated the stock with a sell rating, four have issued a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of Moderate Buy and a consensus target price of $105.79.

Cardinal Health Stock Performance

Shares of CAH stock traded down $4.08 on Friday, hitting $98.90. The stock had a trading volume of 3,445,729 shares, compared to its average volume of 2,288,769. The stock's 50 day moving average is $109.28 and its 200-day moving average is $104.97. The firm has a market capitalization of $24.06 billion, a price-to-earnings ratio of 38.94, a P/E/G ratio of 1.03 and a beta of 0.71. Cardinal Health has a 52-week low of $77.56 and a 52-week high of $116.04.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings data on Thursday, May 2nd. The company reported $2.08 earnings per share for the quarter, beating analysts' consensus estimates of $1.95 by $0.13. Cardinal Health had a net margin of 0.30% and a negative return on equity of 57.44%. The company had revenue of $54.90 billion during the quarter, compared to analysts' expectations of $56.05 billion. During the same period in the prior year, the company posted $1.74 EPS. The firm's revenue for the quarter was up 8.7% on a year-over-year basis. Equities analysts expect that Cardinal Health will post 7.28 earnings per share for the current year.

Cardinal Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Monday, April 1st were paid a $0.5006 dividend. The ex-dividend date was Thursday, March 28th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.02%. Cardinal Health's dividend payout ratio (DPR) is presently 78.74%.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.